108 related articles for article (PubMed ID: 17615972)
1. [Detection of transcriptional activities of tumor-specific survivin promoter in human prostatic carcinoma].
Luo XM; Liu JY; Su MQ; Hao XK
Zhonghua Nan Ke Xue; 2007 Jun; 13(6):502-6. PubMed ID: 17615972
[TBL] [Abstract][Full Text] [Related]
2. [Transcriptional activities of tumor-specific survivin promoter and PSMA promoter and enhancer in human prostate cancer: evaluation and comparison].
Luo XM; Liu JY; Su MQ; Hao XK
Zhonghua Nan Ke Xue; 2012 Feb; 18(2):122-5. PubMed ID: 22568207
[TBL] [Abstract][Full Text] [Related]
3. [Detection and comparison of transcriptional activities of tumor-specific survivin and alpha-fetoprotein promoters in human hepatocellular carcinoma cells].
Kuang G; Huang AL; Tang N
Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):440-2. PubMed ID: 15975279
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.
Ulasov IV; Rivera AA; Sonabend AM; Rivera LB; Wang M; Zhu ZB; Lesniak MS
Cancer Biol Ther; 2007 May; 6(5):679-85. PubMed ID: 17404502
[TBL] [Abstract][Full Text] [Related]
5. [Biological implications of the inhibition of survivin by RNA interference in human androgen-independent prostate carcinoma with highly metastatic potential].
Zhu X; Ning JY; You JF; Wang JL; Cui XL; Fang WG; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):549-54. PubMed ID: 17134550
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of survivin gene expression in PC-3 cells by RNAi].
Shen JJ; Hao XK; Liu JY; Su MQ; Miao YY; Zhang Q
Zhonghua Nan Ke Xue; 2006 Oct; 12(10):890-5. PubMed ID: 17121017
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.
Konopka K; Spain C; Yen A; Overlid N; Gebremedhin S; Düzgüneş N
Cell Mol Biol Lett; 2009; 14(1):70-89. PubMed ID: 18839071
[TBL] [Abstract][Full Text] [Related]
8. [Construction and identification of plasmid vector encoding two survivin shRNA].
Yang GT; Shan YX; Yang DR
Zhonghua Nan Ke Xue; 2006 Jun; 12(6):512-5. PubMed ID: 16833190
[TBL] [Abstract][Full Text] [Related]
9. [Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy].
Zhang Y; Ma H; Liu SL; Liu YX; Zheng DX
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):475-9. PubMed ID: 18642790
[TBL] [Abstract][Full Text] [Related]
10. [Construction of recombinant adenovirus vector containing human survivin gene and its expression in dendritic cells].
Zhu XP; Chen ZZ; Lin X; Hu JD; Li CT; Yang T; Xu ZS; Lü LL; Chen CP; Zhang LH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):791-4. PubMed ID: 16928323
[TBL] [Abstract][Full Text] [Related]
11. [Effect of RNAi-mediated survivin gene silencing on apoptosis of ovarian cancer cell lines SKOV3 and SKOV3/ADM].
Deng KX; Zhong L; Jiang MX; Chen WX; Chen Y; He H
Ai Zheng; 2005 Aug; 24(8):945-50. PubMed ID: 16086871
[TBL] [Abstract][Full Text] [Related]
12. [RNA interference inhibits the expression of survivin and induces the apoptosis of PC-3 cells].
Wang YB; Liu YL; Wang P; Fu XL; Sun ZX
Zhonghua Nan Ke Xue; 2007 Nov; 13(11):983-7. PubMed ID: 18077908
[TBL] [Abstract][Full Text] [Related]
13. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
Yoo J; Lee YJ
Mol Pharmacol; 2007 Dec; 72(6):1586-92. PubMed ID: 17848598
[TBL] [Abstract][Full Text] [Related]
14. Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo.
Zhu ZB; Makhija SK; Lu B; Wang M; Rivera AA; Kim-Park S; Ulasov IV; Zhou F; Alvarez RD; Siegal GP; Curiel DT
Int J Oncol; 2005 Jul; 27(1):237-46. PubMed ID: 15942665
[TBL] [Abstract][Full Text] [Related]
15. [Influence of short hairpin RNA on survivin mRNA expression and chemosensitivity to paclitaxel in ovarian cancer cells].
Yan XJ; Liang LZ; Zeng ZY; Fu LW; Shi Z
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):609-13. PubMed ID: 16202317
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways.
Yang S; Lim M; Pham LK; Kendall SE; Reddi AH; Altieri DC; Roy-Burman P
Cancer Res; 2006 Apr; 66(8):4285-90. PubMed ID: 16618753
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
18. Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells.
Zhang HZ; Wang Y; Gao P; Lin F; Liu L; Yu B; Ren JH; Zhao H; Wang R
Cancer Biol Ther; 2006 Nov; 5(11):1457-61. PubMed ID: 17012855
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
[TBL] [Abstract][Full Text] [Related]
20. [Effect of inhibiting survivin expression with antisense oligodeoxynucleotides on sensitivity of hepatocellular carcinoma cell lines HepG2 and HepG2/ADM to adriamycin].
Dai DJ; Lu CD; Guo JM; Zhang J
Ai Zheng; 2005 Aug; 24(8):951-7. PubMed ID: 16086872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]